Wanxin Bio-Technology
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of drugs and vaccines. The company's products specialize in the genetically engineered recombinant protein drugs and vaccines which respond to a wide range of diseases, including malaria and hepatitis.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Primary Office
- Shanghai
- China
Wanxin Bio-Technology Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Wanxin Bio-Technology‘s full profile, request access.
Request full access to PitchBook